Services
Discovery
AI Drug Discovery
Target identification
Drug repurposing
Virtual screening
Molecular dynamics
Lead optimisation & ADMET
AI Drug Discovery
Data
Bioinformatics & Multi-Omics
Multi-omics analytics
Biomarker discovery
Clinical bioinformatics
Transcriptomics
Proteomics
Bioinformatics & Multi-Omics
Laboratory
Translational Biology
Target validation
PCR/qPCR assay development
Gene synthesis
Protein expression
Cell culture
Translational Biology
Product
Molecular Diagnostics
Companion diagnostics
Liquid biopsy
Diagnostic kit development
OEM manufacturing
Validation & Regulatory
Molecular Diagnostics
Every service carries a published scope, duration and price band.
Platform
Discovery
Autonomous Asset Discovery
Asset surfacing
Novel targets
Traceable evidence
Autonomous Asset Discovery
Evaluation
In-Silico Evaluation Suite
Docking & screening
Simulation
ADMET & toxicity
In-Silico Evaluation Suite
Commercial
Market & Commercial Insight
Pricing & access
Competition
Back-tested forecasts
Market & Commercial Insight
Clinical
Clinical Operations
Trial digital twin
Feasibility
Adaptive design
Clinical Operations
Business
Business Development
Valuation
Deal benchmarking
Diligence
Business Development
Five platforms, one evidence layer - the same corpus, ontology and probability of success.
Research
Fellowship
About
Contact

News & media

Latest Updates

Coverage of our work, and the announcements behind it.

Nothing published here yet. For press enquiries, tell us what you are working on and we will point you to the right person.